News By Tag
* Insight Pharma Reports
* Pharma Reports
* Parkinson S
* Parkinson S Disease
* More Tags...
News By Location
Insight Pharma Reports Announces Biomarkers in Parkinson’s Disease Report
Understand the market growth of biomarkers, advantages, disadvantages, and validation techniques
Experts interviewed in this report include:
· Dr. Andrew West, Associate Professor of Neurology and Neurobiology and Co-Director, Center for Neurodegeneration and Experimental Therapeutics
· Dr. Xuemei Huang, Professor and Vice Chair, Department of Neurology; Professor of Neurosurgery, Radiology, Pharmacology, and Kinesiology Director; Hershey Brain Analysis Research Laboratory for Neurodegenerative Disorders, Penn State University-Milton, S. Hershey Medical Center Department of Neurology
· Dr. Andreas Jeromin, CSO and President of Atlantic Biomarkers
Also available in this report is extensive survey data exclusively conducted for this report. Illustrated by 30 figures captured in an in-depth analysis, this section features insight into targets under investigation, challenges, advantages, and desired features of future diagnostic applications.
Insight Pharma Reports also engineered a table of clinical trial information and pipeline data from multiple databases related to Parkinson’s Disease. This table features companies, targets, clinical phases, and brief target/product descriptions.
For more information and to purchase this Insight Pharma Report, visit: http://www.insightpharmareports.com/
or contact Kerri Kelley at firstname.lastname@example.org or 781-972-1347.
About Insight Pharma Reports
Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical, biotech, diagnostic, consulting, and financial companies to keep abreast of the latest advances in pharmaceutical R&D, their potential applications and business impacts, and their current and future position in the marketplace. Insight Pharma Reports is a division within Cambridge Healthtech Institute. http://www.InsightPharmaReports.com
Insight Pharma Reports offers our Affiliated Reports Collection which provides a repository of additional scientific and business resources. For more information, visit http://www.insightpharmareports.com/